{
  "docId": "019de077-880d-703f-ad59-c0ee1df8dfeb",
  "docSlug": "3a2edb97bafa9f0a0205c3f0e878214f",
  "documentTitle": "Legend Biotech | Investor Presentation Deck | 26 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 26,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a map-based visualization to link regional regulatory status with patient population data.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-880d-703f-ad59-c0ee1df8dfeb/12",
  "deckHref": "/decks/019de077-880d-703f-ad59-c0ee1df8dfeb",
  "deckJsonHref": "/decks/019de077-880d-703f-ad59-c0ee1df8dfeb.json",
  "deckAnchorHref": "/decks/019de077-880d-703f-ad59-c0ee1df8dfeb#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.25,
        "x": 0.45,
        "y": 0.645
      },
      "kind": "callout",
      "text": "South America\nANVISA³ approval for 2L+ MM",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c9b3613-fda1-49a0-b3b6-bde0ee274b91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.22,
        "x": 0.75,
        "y": 0.48
      },
      "kind": "callout",
      "text": "APAC\nMHLW¹ approval for 4L+ MM",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90c07143-afb2-4a4a-b3af-565dbff9a2df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.22,
        "x": 0.64,
        "y": 0.3
      },
      "kind": "callout",
      "text": "Europe\nEC approval for 2L+ MM",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df844a23-bc54-4c16-ba72-8bb9e7b0e586",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.22,
        "x": 0.4,
        "y": 0.415
      },
      "kind": "callout",
      "text": "North America\nFDA approval for 2L+ MM",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f864dc7f-8b60-4034-96b0-eccdcc72b3c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.6,
        "x": 0.4,
        "y": 0.2
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49947861-18d3-4184-9454-08398ef272aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.38,
        "x": 0.02,
        "y": 0.275
      },
      "kind": "paragraph",
      "text": "MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR CAR-T THERAPY\nFrontline: ~52k patients\n2L to 4L: ~80k patients\n5L+: ~22k patients",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e2e695c-f688-413d-b11e-f6b608eaa4ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.04,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. MHLW is the Ministry of Health, Labour and Welfare in Japan. 2. ANVISA is the Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária. 2L denotes second-line. 4L denotes fourth-line. 5L+ denotes fifth-line and beyond.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "811dccc8-81e7-4f0f-9c41-dd6110362627",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Unlocking the Blockbuster Global Market Opportunity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "acbd1795-9e46-4cc9-a12f-800c614320b2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Market Segmentation Pyramid",
      "slug": "market-segmentation-pyramid",
      "agent": null,
      "layer": "slide",
      "matchId": "d8e09a50-bbe3-4591-b3f4-a8670fde4bf3",
      "evidence": "Frontline: ~52k patients; 2L to 4L: ~80k patients; 5L+: ~22k patients",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "map-spatial",
      "slug": null,
      "matchId": "98d5392a-15c7-4076-8dd2-f0489097283b",
      "evidence": "Use of a world map to categorize regional regulatory status.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 12,
      "beatId": "4e1c0e7a-c66e-4e61-afc3-03ef13607276",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The market sizing is discussed on page 12, unlocking the blockbuster global market opportunity.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 25,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "6b23062f-1e91-4b0d-ab29-cd4f465a9867",
      "evidence": "The deck presents a clear narrative around CARVYKTI's achievements and future potential, aligning with the Golden Circle framework.",
      "position": 1,
      "objective": "Show how CARVYKTI and Legend Biotech's pipeline align with the why, what, and how of transforming cancer care",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}